Maple Leaf Foods: Cooking Up Growth in Plant-Based Protein

Maple Leaf Foods Inc. (TSX:MFI) stock looks like a great target, as the company has bet on the promising plant-based food market.

| More on:
Technology

Image source: Getty Images

Maple Leaf Foods (TSX:MFI) is a Mississauga-based company that produces food products in the United States, Canada, Japan, China, and around the world. Today, I want to discuss how this Canadian staple looks after its earnings reveal. Moreover, I want to explore the potential of its determined foray into the plant-based food alternatives market. Let’s dive in.

How has this stock performed over the past year?

Shares of Maple Leaf Foods were up 11% in early afternoon trading on Thursday, May 11. That pushed the stock back into the black in the year-to-date period in 2023. Its shares are up 5.4% year over year. Investors who want to see more of its recent performance can toggle the interactive price chart below.

Should investors be happy with the company’s recent earnings?

This company unveiled its first-quarter (Q1) fiscal 2023 earnings before markets opened on May 11. Maple Leaf reported total sales growth of 4.3% to $1.17 billion in Q1. Its Meat Protein Group achieved sales growth of 5% to $1.14 billion, making up the bulk of revenues. Meanwhile, its adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) came in at $87.3 million, as it also posted an adjusted EBITDA margin of 7.6%. That was 100 basis points (bps) better than the previous year.

Maple Leaf’s Plant Protein Group is still in its early stages of establishment. This segment reported total sales of $37.4 million. Moreover, its adjusted EBITDA climbed 60% year over year to a loss of $12.0 million. The company is targeting a neutral or positive adjusted EBITDA for this segment in the second half of 2023.

Overall, the company reported a net loss of $57.7 million, or $0.48 per share, in Q1 of fiscal 2023. Maple Leaf’s earnings were hit by its Meat Protein Group performance, as pork market headwinds, cost inflation, and increased start-up expenses presented challenges. Despite its size relative to the Meat Protein segment, the Plant Protein Group was the bright spot for Maple Leaf in the opening quarter of the year.

Here’s why investors should be excited about Maple Leaf Foods’s future

Maple Leaf expects its Meat Protein Group to deliver mid- to high-digit sales growth in 2023. Meanwhile, it is also forecasting an adjusted EBITDA margin expansion in the range of 14-16%.

As stated, the company expects it Plant Protein Group to deliver neutral or positive adjusted EBITDA in the second half of fiscal 2023. Investors should be eager to get in on the plant-based food industry. The Good Food Institute (GFI) recently valued the plant-based food market in the United States at $8 billion in 2022. According to the report, six in 10 households bought a plant-based food last year.

Future Market Insights recently estimated that the global plant-based food market was valued at US$11.3 billion in 2023. The report projected that this market would grow to US$35.9 billion by 2033. That would represent a compound annual growth rate of 12% over the forecast period.

Maple Leaf Foods: Why I’m buying this stock today

Shares of Maple Leaf are trading in favourable value territory compared to its industry peers at the time of this writing. Moreover, it is geared up for very strong earnings growth in the quarters ahead. The stock currently offers a quarterly dividend of $0.21 per share. That represents a 3% yield.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Ambrose O'Callaghan has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

More on Investing

Stethoscope with dollar shaped cord
Investing

1 Magnificent Healthcare Stock Down 46% to Buy and Hold Forever

This TSX healthcare technology stock is trading at a considerable discount but boasts substantial long-term growth potential. It can be…

Read more »

calculate and analyze stock
Investing

Where I’d Invest $6,000 in The TSX Today

I am bullish on these two TSX stocks due to their solid underlying businesses and healthy growth prospects.

Read more »

Silver coins fall into a piggy bank.
Stocks for Beginners

Where I’d Invest My Savings in the TSX Today

If you have some savings ready to invest, then these three investments are top choices among analysts.

Read more »

Dividend Stocks

This Canadian Monthly Dividend Stock Pays a Stunning 9% Yield

Pro REIT is a Canada-based real estate company that offers you a forward yield of 9% in 2025. Is this…

Read more »

clock time
Bank Stocks

1 Magnificent Financial Stock Down 23% to Buy and Hold Forever

This top TSX financial stock is trading well below its recent peak, but its long-term fundamentals remain rock solid.

Read more »

dividend growth for passive income
Bank Stocks

This Canadian Bank Pays 4.75% and Could Double Your Money by 2030

A Canadian bank is a top pick for its lucrative dividend and potential to double your money in five years.

Read more »

TFSA (Tax free savings account) acronym on wooden cubes on the background of stacks of coins
Dividend Stocks

How I’d Invest $7,000 in My TFSA for $660 in Tax-Free Annual Income

Canadians looking for ways to make the most of the new TFSA contribution room should consider investing in these two…

Read more »

oil and natural gas
Energy Stocks

1 Magnificent Canadian Energy Stock Down 23% to Buy and Hold for Decades

This oil and gas producer has increased its dividend annually for more than two decades.

Read more »